In this work we studied the in vitro toxicity of artemisinin and its chemical derivatives deoxoartemisinin, artemether and arteether against stationary phase promastigotes of Leishmania (L) mexicana. Results presented in this work include dramatic changes in parasite morphology when they were cultured in the presence of these chemicals. These changes were accompanied by the parasite's lost of mobility and eventual death after four days of culturing. We also observed that parasite growth was much more effectively reduced in cultures carried out in the presence of either artemisinin or its semi-synthetic derivatives than the reference drug N-methyl meglumine (Glucantime TM , Rhone Poulenc, France). The compounds tested in this work were not toxic to Hela cells cultured in vitro. This is the first report describing the promising potential use of Qinghaosu (artemisinin) and related chemical analogues to treat L (L) mexicana infections.
Leishmaniasis comprises one of the most important parasitic diseases in the world [1] . According to World Health Organization, leishmaniasis has been widespread in 22 countries in the New World and in 66 nations in the Old World. The overall prevalence worldwide is about 12 million infected people and the population at risk is about 350 million [2] . Worldwide, two million new cases occur each year, and in many endemic areas disease incidence is set to increase [3] . Leishmaniasis presents a spectrum of clinical manifestations and results from an infection with the protozoan parasite Leishmania spp. Chiclero's ulcer is one of the existing forms of cutaneous leishmaniasis (CL) and is due to infection mainly by Leishmania (L) mexicana, which is highly endemic in some parts of Mexico and Central America [3, 4] .
In the Yucatan peninsula of Mexico, conventional therapy based on antimonial administration to patients living in the rain forest is not regularly performed. This treatment is expensive and patients frequently use radical procedures such as battery liquid spread on the skin lesion or cutting off the entire lesion with a heated blade [4] .
There are several reports showing increasing resistance to antimonials in some endemic areas [5] [6] [7] [8] [9] [10] . Therefore, the discovery and development of new drugs is considered a priority by the Tropical Diseases Program of the World Health Organization (TDR/WHO) [1] . Different research groups have been working on the identification of plants and their chemical products to treat cutaneous leishmaniasis [11] [12] [13] .
The plant Artemisia annua L. (Asteraceae) has been used for many centuries in Chinese traditional medicine as a treatment for fever and malaria. [14] and named artemisinin or qinghaosu (a). Subsequent studies of the structure/activity relationship led to the preparation of semi-synthetic derivatives, such as deoxoartemisinin (b), arteether (c), and artemether (d), among others [14, 15] . Artemisinin derivatives, such as artesunate and arteether, either alone or in combination with other drugs, are being used as a remedy for malaria in many endemic areas [16] . This has prompted interest in the discovery of new antiprotozoal applications of these drugs. The only two existing reports on the leishmanicidal action of artemesinin and its derivatives have indicated that these compounds display toxicity against L. major and L. donovani [17, 18] . However, to our knowledge, this is the first report investigating toxicity of artemisinin and its derivatives against L (L) mexicana promastigotes. In this work, we undertook a study aimed to test the in vitro capacity of artemisinin and its chemical derivatives deoxoartemisinin, arteether and artemether to change parasite-morphology and destroy L (L) mexicana promastigotes.
Leishmanicidal activity: Artemisinin and its chemical analogues (10 μg/mL) completely destroyed one hundred thousand L (L) mexicana promastigotes cultured in vitro for 96 hours. However, at 48 hr and onwards the number of parasites cultured with either these compounds or N-methyl glucamine (Glucantime TM , Rhone Poulenc, France) displayed a significant (p<0.05) reduction in comparison to control cultures ( Figure 1 ). There were no reductions in parasites' body lengths and perimeters when cultured with glucantime, artemisinin, deoxoartemisinin, artemether and arteether after 48 hr of parasite culture. However, at 72 and 96 hr, parasites cultured with either artemisinin or its derivatives presented bodies' lengths and perimeters significantly reduced as compared to the control group (p<0.05; Figures 2 A, B) . Interestingly, after 96 hours of in vitro culture, only parasites in the control and reference drug groups survived. At this time the numbers of promastigotes in these two groups were not significantly different (p>0.05). All parasites cultured with artemisinin, deoxoartemisinin, arthemether and arteether died after 96 hours of in vitro culture and both lengths and perimeters corresponded to zero (Figures 1, 2 A, B) . **** **** * ***** Parasites treated with 100 μg/mL of artemisinin and its derivatives showed results very similar to those displayed by parasites cultured with 10 μg/mL of these compounds. Table I shows IC 50 , IC 100 and LD 50 values of the compounds studied. The strongest activitiy against L (L) mexicana promastigotes was found with artemisinin, followed by its chemical derivatives. Interestingly, even as little as 10 μg of any of these compounds was more effective than 10 μg of the reference drug to kill promastigotes from 72 hr onwards (Figure 1 ). The highest difference in LD 50 values was found between artemisinin and the reference drug N-methyl glucamine (Table I) . refringency and integrity of the monolayer of Hela cells cultured with 100 μg/mL of artemisinin, its chemical derivatives and glucantime were not different from those of control cultures. Viability tests using trypan blue exclusion showed similar results between control and experimental cultures (>90%) after 96 hr of culture.
Qinghaosu (artemisinin) and its derivatives have been considered as an alternative to treat human malaria. However, there is no experience regarding the use of these molecules to treat any form of leishmaniasis. This report is the first that describes the anti-L (L) mexicana activitiy of artemisinin and three of its semi-synthetic derivatives, and provides valuable information that adds to the few existing reports on the leishmanicidal activity of qinghaosu. Results showed differences in the level of in vitro toxicity and morphological changes of L (L) mexicana promastigotes treated with artemisinin and related analogues. We concluded that as little as 10 μg of any of the tested compounds, artemisinin, deoxoartemisinin, arteether and artemether, provoke severe morphological changes and the eventual death of parasites cultured in vitro. There was no toxicity of these compounds to a human cell line (Hela cells) cultured in vitro. Therefore, exciting opportunities now exist to seriously consider the use of these compounds to treat experimental and naturally acquired human cutaneous leishmaniasis. arteether, artemether and Glucantime TM (N-methyl glucamine, Rhone Poulenc, France) were dissolved in a known volume of DMSO (Dimethylsulfoxide; Sigma U.S.A.) and diluted (1%) with culture medium. One hundred thousand infective stationary phase promastigotes were cultured together with as little as 10 µg/mL of one of artemisinin, deoxoartemisinin, arteether, artemether and glucantime (used as reference drug) in 1% DMSO. As control, parasites were suspended in complete culture media containing 1% DMSO. Parasites so treated were counted in triplicate, during four days, using a hemacytometer and a vertical microscope (40X objective). Morphology of parasites' body and mobility were assessed, in the same cultures, by daily measurement of parasites' body lengths and perimeters of 15 randomly selected parasites per group using a computer linked to a Telaval II inverted microscope (Axiodoc-A, CarlZeiss, Germany), calibrated according to the manufacturer's instructions. The 50% and 100% Inhibitory Concentration (IC 50 and IC 100 ) are the doses required to produce either 50% or 100% reduction of parasite-mobility.
LD 50 values:
The 50% Lethal Dose (LD 50 ) is one way to measure the short-term poisoning potential (acute toxicity) of a chemical compound and is the concentration of the tested drug required to produce the death of 50% of parasites under study. The LD 50 was determined by counting living promastigotes after an incubation period of 48, 72 and 96 hours. Data were analyzed with a computer program, LdP Line ® .
Cytotoxicity study: The cytotoxic activity was examined using Hela cells: This cell line was cultured in vitro in culture media supplemented with 10% FCS and incubated in a mixture of air (95%) and CO 2 (5%) at 37 o C. Tissue culture plates (24 well plates, Falcon U.S.A.) were seeded at 5 X 10 4 cells/well in culture media. Artemisinin, its derivatives or glucantime were added at a concentration of 10 or 100 μg/mL, and were inspected every day during four weeks. Monolayers of Hela cells treated with culture media alone were used as a control.
